17,796 Shares in Cameco Corporation $CCJ Bought by Kelleher Financial Advisors

Key Points

• Kelleher Financial Advisors acquired 17,796 Cameco shares in the second quarter, valued at approximately $1.81 million. Institutional investors collectively own 70.21% of the company.
• Cameco’s latest quarterly results missed expectations, with earnings per share of $0.13 versus a $0.26 consensus estimate, while revenue fell 6.8% year over year to $573.1 million.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $145.68, compared with the stock’s reported price of $97.74.

Kelleher Financial Advisors acquired a new stake in shares of Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,796 shares of the basic materials company's stock, valued at approximately $1,813,000.

A number of other hedge funds also recently bought and sold shares of the company. Bison Wealth LLC grew its stake in shares of Cameco by 16.1% during the 4th quarter. Bison Wealth LLC now owns 21,448 shares of the basic materials company's stock valued at $1,102,000 after purchasing an additional 2,975 shares during the period. AQR Capital Management LLC lifted its stake in shares of Cameco by 16.6% in the 1st quarter. AQR Capital Management LLC now owns 9,547 shares of the basic materials company's stock worth $393,000 after purchasing an additional 1,361 shares during the period. Integrated Wealth Concepts LLC boosted its holdings in shares of Cameco by 48.7% in the first quarter. Integrated Wealth Concepts LLC now owns 8,485 shares of the basic materials company's stock worth $349,000 after buying an additional 2,780 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Cameco by 11.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 604,841 shares of the basic materials company's stock worth $24,895,000 after buying an additional 64,512 shares during the last quarter. Finally, NewGen Equity Long Short Fund bought a new stake in Cameco during the second quarter valued at approximately $14,252,000. Hedge funds and other institutional investors own 70.21% of the company's stock.

Cameco Trading Down 0.0%

Shares of CCJ stock opened at $97.74 on Friday. The company has a current ratio of 3.06, a quick ratio of 2.10 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $42.57 billion, a price-to-earnings ratio of 165.66, a price-to-earnings-growth ratio of 1.67 and a beta of 1.05. Cameco Corporation has a 12-month low of $68.96 and a 12-month high of $135.24. The stock's 50-day moving average price is $96.44 and its 200-day moving average price is $108.52.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its quarterly earnings results on Friday, July 31st. The basic materials company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.26 by ($0.13). The firm had revenue of $573.06 million for the quarter, compared to the consensus estimate of $579.60 million. Cameco had a net margin of 10.20% and a return on equity of 7.59%. Cameco's quarterly revenue was down 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.71 earnings per share. Equities research analysts predict that Cameco Corporation will post 1.27 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CCJ has been the subject of a number of research reports. Sanford C. Bernstein reaffirmed an "outperform" rating and set a $135.00 target price on shares of Cameco in a report on Monday, June 15th. Weiss Ratings cut shares of Cameco from a "hold (c)" rating to a "hold (c-)" rating in a research note on Wednesday. Royal Bank Of Canada boosted their price objective on shares of Cameco from $160.00 to $175.00 and gave the company an "outperform" rating in a research report on Monday, June 29th. Bank of America cut their price objective on shares of Cameco from $143.00 to $140.00 and set a "buy" rating for the company in a research report on Thursday, July 9th. Finally, William Blair assumed coverage on Cameco in a research note on Monday, April 20th. They issued an "outperform" rating for the company. Fourteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $145.68.

Cameco Profile

Cameco Corporation NYSE: CCJ is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company's operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source